# A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins

> **NCT07634484** · PHASE4 · RECRUITING · sponsor: **Kowa Company, Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Pemafibrate 0.2 mg/day
- **DRUG:** Pemafibrate 0.4 mg/day
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07634484
- **Lead sponsor:** Kowa Company, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07634484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07634484, "A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07634484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*